247 related articles for article (PubMed ID: 26936175)
1. [How some commensal bacteria would exacerbate colorectal carcinogenesis?].
Raisch J; Dalmasso G; Bonnet R; Barnich N; Bonnet M; Bringer MA
Med Sci (Paris); 2016 Feb; 32(2):175-82. PubMed ID: 26936175
[TBL] [Abstract][Full Text] [Related]
2. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
Bruneau A; Baylatry MT; Joly AC; Sokol H
Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
[TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
[TBL] [Abstract][Full Text] [Related]
4. The gut microbiota and colon cancer.
Garrett WS
Science; 2019 Jun; 364(6446):1133-1135. PubMed ID: 31221845
[No Abstract] [Full Text] [Related]
5. The impact of the gut microbiota on prognosis after surgery for colorectal cancer - a systematic review and meta-analysis.
Colov EP; Degett TH; Raskov H; Gögenur I
APMIS; 2020 Feb; 128(2):162-176. PubMed ID: 32017196
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota imbalance and colorectal cancer.
Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.
Brennan CA; Garrett WS
Nat Rev Microbiol; 2019 Mar; 17(3):156-166. PubMed ID: 30546113
[TBL] [Abstract][Full Text] [Related]
8. Intestinal microbiota and its association with colon cancer and red/processed meat consumption.
Abu-Ghazaleh N; Chua WJ; Gopalan V
J Gastroenterol Hepatol; 2021 Jan; 36(1):75-88. PubMed ID: 32198788
[TBL] [Abstract][Full Text] [Related]
9. Do biofilms confer a pro-carcinogenic state?
Dejea CM; Sears CL
Gut Microbes; 2016; 7(1):54-7. PubMed ID: 26939852
[TBL] [Abstract][Full Text] [Related]
10. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
Leung A; Tsoi H; Yu J
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
[TBL] [Abstract][Full Text] [Related]
12. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanistic pathway of colorectal carcinogenesis associated with intestinal microbiota.
Mandal P
Anaerobe; 2018 Feb; 49():63-70. PubMed ID: 29277623
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota, Inflammation, and Colorectal Cancer.
Brennan CA; Garrett WS
Annu Rev Microbiol; 2016 Sep; 70():395-411. PubMed ID: 27607555
[TBL] [Abstract][Full Text] [Related]
16. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.
Kostic AD; Chun E; Robertson L; Glickman JN; Gallini CA; Michaud M; Clancy TE; Chung DC; Lochhead P; Hold GL; El-Omar EM; Brenner D; Fuchs CS; Meyerson M; Garrett WS
Cell Host Microbe; 2013 Aug; 14(2):207-15. PubMed ID: 23954159
[TBL] [Abstract][Full Text] [Related]
17.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
18. RETRACTED: Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis.
Wang WY; Zhou H; Wang Z; Zhang YH
Cancer Treat Res Commun; 2022; 32():100536. PubMed ID: 35567912
[TBL] [Abstract][Full Text] [Related]
19. Microbiome: Microbial mystery.
DeWeerdt S
Nature; 2015 May; 521(7551):S10-1. PubMed ID: 25970451
[No Abstract] [Full Text] [Related]
20. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.
Rye MS; Garrett KL; Holt RA; Platell CF; McCoy MJ
PLoS One; 2022; 17(1):e0262416. PubMed ID: 34995318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
